Covered recipient · General Payments record
TAMMY G WATTS
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Adult Health
General Payments · PY2021–2023
$3,606.15
- Reported across 229 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $565.97 | 27 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $198.63 | 13 |
| ITI, Inc. | $127.27 | 1 |
| IMPEL PHARMACEUTICALS INC. | $66.86 | 4 |
| Lilly USA, LLC | $50.37 | 3 |
| Amgen Inc. | $26.58 | 1 |
| ACADIA Pharmaceuticals Inc | $23.18 | 1 |
| Otsuka America Pharmaceutical, Inc. | $20.27 | 1 |
| Almatica Pharma Inc. | $18.75 | 1 |
| Azurity Pharmaceuticals, Inc. | $17.38 | 1 |
| Teva Pharmaceuticals USA, Inc. | $16.68 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2023 20212022
Record-level detail is published for PY2023; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $25.89 | 01/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1010179265 | CMS |
| ABBVIE INC. | $12.97 | 01/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1010179269 | CMS |
| ABBVIE INC. | $5.29 | 01/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1010179273 | CMS |
| ABBVIE INC. | $18.83 | 02/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1010179277 | CMS |
| ABBVIE INC. | $15.95 | 03/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1010179281 | CMS |
| ABBVIE INC. | $11.64 | 03/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1010179285 | CMS |
| ABBVIE INC. | $4.68 | 03/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1010179289 | CMS |
| ABBVIE INC. | $4.35 | 03/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1010179293 | CMS |
| ABBVIE INC. | $17.99 | 04/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1010179297 | CMS |
| ABBVIE INC. | $27.48 | 05/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1010179301 | CMS |
| ABBVIE INC. | $5.39 | 06/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1010179305 | CMS |
| ABBVIE INC. | $17.44 | 06/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1010179309 | CMS |
| ABBVIE INC. | $30.73 | 07/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1010179313 | CMS |
| ACADIA Pharmaceuticals Inc | $23.18 | 05/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1053223865 | CMS |
| Almatica Pharma LLC | $18.75 | 03/28/2023 | Food and Beverage | Undisputed | 01/23/2026 | 993470117 | CMS |
| Amgen Inc. | $26.58 | 04/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020513591 | CMS |
| Azurity Pharmaceuticals, Inc. | $17.38 | 01/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 991802491 | CMS |
| IMPEL PHARMACEUTICALS INC. | $15.73 | 02/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | 989445661 | CMS |
| IMPEL PHARMACEUTICALS INC. | $17.51 | 03/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 989445669 | CMS |
| IMPEL PHARMACEUTICALS INC. | $16.00 | 04/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 989445679 | CMS |
| IMPEL PHARMACEUTICALS INC. | $17.62 | 05/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 989445687 | CMS |
| ITI, Inc. | $127.27 | 02/28/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1041196803 | CMS |
| Lilly USA, LLC | $14.26 | 02/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1033536733 | CMS |
| Lilly USA, LLC | $20.26 | 04/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1033708889 | CMS |
| Lilly USA, LLC | $15.85 | 06/26/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1033724023 | CMS |
| Otsuka America Pharmaceutical, Inc. | $20.27 | 03/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1015581237 | CMS |
| Teva Pharmaceuticals USA, Inc. | $16.68 | 02/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1056699581 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023
- Source files
- Dataset page · Bulk file · PY2021 , PY2022 , PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.